How to identify patients who would benefit from delayed-matured oocytes insemination: a sibling oocyte and ploidy outcome study

生发泡 卵母细胞 受精 男科 生物 卵胞浆内精子注射 人类受精 胚泡 体外受精 妇科 胚胎 人口 医学 精子 胚胎发生 遗传学 环境卫生
作者
Ibrahim Elkhatib,Daniela Nogueira,Aşina Bayram,Andrea Abdala,Raquel Del Gallego,Laura Melado,Neelke De Munck,Barbara Lawrenz,Human M. Fatemi
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:38 (8): 1473-1483 被引量:17
标识
DOI:10.1093/humrep/dead129
摘要

STUDY QUESTION: Which patients might benefit from insemination of delayed-matured oocytes? SUMMARY ANSWER: Delayed-matured oocytes had a ≥50% contribution to the available cohort of biopsied blastocysts in patients with advanced maternal age, low maturation, and/or low fertilization rates. WHAT IS KNOWN ALREADY: Retrieved immature oocytes that progress to the MII stage in vitro could increase the number of embryos available during ICSI cycles. However, these delayed-matured oocytes are associated with lower fertilization rates and compromised embryo quality. Data on the ploidy of these embryos are controversial, but studies failed to compare euploidy rates of embryos derived from delayed-matured oocytes to patients' own immediate mature sibling oocytes. This strategy efficiently allows to identify the patient population that would benefit from this approach. STUDY DESIGN, SIZE, DURATION: This observational study was performed between January 2019 and June 2021 including a total of 5449 cumulus oocytes complexes from 469 ovarian stimulation cycles, from which 3455 inseminated matured oocytes from ICSI (n = 2911) and IVF (n = 544) were considered as the sibling controls (MII-D0) to the delayed-matured oocytes (MII-D1) (n = 910). Euploidy rates were assessed between delayed-matured (MII-D1) and mature sibling oocytes (MII-D0) in relation to patients' clinical characteristics such as BMI, AMH, age, sperm origin, and the laboratory outcomes, maturation, fertilization, and blastocyst utilization rates. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 390 patients undergoing IVF/ICSI, who had at least one metaphase I (MI) or germinal-vesicle (GV) oocyte on the day of oocyte collection (Day 0), which matured in 20-28 h after denudation were included. MI and GV oocytes that matured overnight were inseminated on the following day (Day 1, MII-D1) by ICSI. Only cycles planned for preimplantation genetic testing for aneuploidy using fresh own oocytes were included. MAIN RESULTS AND THE ROLE OF CHANCE: Fertilization (FR) and blastocyst utilization rates were significantly higher for MII-D0 compared to delayed-matured oocytes (MII-D1) (69.5% versus 55.9%, P < 0.001; and 59.5% versus 18.5%, P < 0.001, respectively). However, no significant difference was observed in the rate of euploid embryos between MII-D0 and MII-D1 (46.3% versus 39.0%, P = 0.163). For evaluation of the benefit of inseminating MI/GV oocytes on D1 per cycle in relation to the total number of biopsied embryos, cycles were split into three groups based on the proportion of MII-D1 embryos that were biopsied in that cycle (0%, 1-50%, and ≥50%). The results demonstrate that patients who had ≥50% contribution of delayed-matured oocytes to the available cohort of biopsied embryos were those of advanced maternal age (mean age 37.7 years), <10 oocytes retrieved presenting <34% maturation rate, and <60% fertilization rate. Every MII oocyte injected next day significantly increased the chances of obtaining a euploid embryo [odds ratio (OR) = 1.83, CI: 1.50-2.24, P < 0.001] among MII-D1. The odds of enhanced euploidy were slightly higher among the MII-D1-GV matured group (OR = 1.78, CI: 1.42-2.22, P < 0.001) than the MII-D1-MI matured group (OR = 1.54, CI: 1.25-1.89, P < 0.001). Inseminating at least eight MII-D1 would have >50% probability of getting a euploid embryo among the MII-D1 group. LIMITATIONS, REASONS FOR CAUTION: ICSI of MII-D1 was performed with the fresh or frozen ejaculates or testicular samples from the previous day. The exact timing of polar body extrusion of delayed-matured MI/GV was not identified. Furthermore, the time point of the final oocyte maturation to MII for the immature oocytes and for the oocytes inseminated by IVF could not be identified. WIDER IMPLICATIONS OF THE FINDINGS: The results of this study might provide guidance to the IVF laboratories for targeting the patient's population who would benefit from MII-D1 ICSI without adhering to unnecessary costs and workload. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. There are no conflicts of interest to be declared for any of the authors. There are no patents, products in development, or marketed products to declare. TRIAL REGISTRATION NUMBER: N/A.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lee完成签到,获得积分10
1秒前
1秒前
苹果骑士完成签到,获得积分10
1秒前
1秒前
jindex完成签到,获得积分10
2秒前
乖拉完成签到,获得积分10
2秒前
2秒前
在九月完成签到 ,获得积分10
3秒前
酷酷怜雪完成签到 ,获得积分10
3秒前
3秒前
4秒前
吕奎完成签到,获得积分10
4秒前
爱撒娇的朋友完成签到,获得积分10
4秒前
yongziwu完成签到,获得积分0
4秒前
Amy完成签到,获得积分0
5秒前
5秒前
啦啦啦完成签到 ,获得积分10
5秒前
儒雅山兰完成签到,获得积分10
6秒前
daikai完成签到,获得积分10
6秒前
Sevi完成签到,获得积分10
6秒前
6秒前
Huangzhisong发布了新的文献求助10
7秒前
我爱坏女人完成签到,获得积分20
7秒前
潇洒的辣条完成签到,获得积分10
7秒前
Cc发布了新的文献求助10
7秒前
弹指一挥间完成签到,获得积分10
7秒前
甜屁儿完成签到 ,获得积分10
7秒前
7秒前
暖阳完成签到 ,获得积分10
7秒前
zdl完成签到,获得积分10
8秒前
8秒前
超级大肥宅完成签到,获得积分10
8秒前
一土它小木登子完成签到,获得积分10
9秒前
好嘞完成签到 ,获得积分10
9秒前
yy发布了新的文献求助10
9秒前
9秒前
SHUNLI0205发布了新的文献求助10
10秒前
10秒前
李健的粉丝团团长的应助被dde采纳,获得10
11秒前
科研通AI6.4的应助被dde采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152197
求助须知:如何正确求助?哪些是违规求助? 9548933
关于积分的说明 21688809
捐赠科研通 7740419
什么是DOI,文献DOI怎么找? 3425136
关于科研通互助平台的介绍 2550342
邀请新用户注册赠送积分活动 2468584